Targeting eicosanoid pathways in the development of novel anti-influenza drugs.

about

Mechanistic perspective of the oxido-immunopathologic resolution property of kolaviron in mice influenza pneumonitis.Monocytic Myeloid-Derived Suppressor Cells in Chronic Infections.Re-understanding anti-influenza strategy: attach equal importance to antiviral and anti-inflammatory therapies

P2860

Q39002769-7E0FFC43-984C-48E3-9B2A-3B66D2B0DCBD Q47550777-77D1F052-22E3-43C4-A226-D09BB94B98FA Q57930420-55F7DC17-870F-4DE0-81A1-C8AE900C08E3

P2860

Targeting eicosanoid pathways in the development of novel anti-influenza drugs.

Item

http://www.wikidata.org/entity/Q38255645

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Targeting eicosanoid pathways in the development of novel anti-influenza drugs.

@en

type

Item

label

Targeting eicosanoid pathways in the development of novel anti-influenza drugs.

@en

prefLabel

Targeting eicosanoid pathways in the development of novel anti-influenza drugs.

@en

P1476

Targeting eicosanoid pathways in the development of novel anti-influenza drugs.

@en

P2093

François Coulombe

http://www.w3.org/2001/XMLSchema#string

Maziar Divangahi

http://www.w3.org/2001/XMLSchema#string

P2860

The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza

Zanamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments

Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments

Regulating the adaptive immune response to respiratory virus infection

Indomethacin and aspirin abolish prostaglandin release from the spleen

Leukotrienes: underappreciated mediators of innate immune responses

Inhibition of prostaglandin E2 synthesis by SC-560 is independent of cyclooxygenase 1 inhibition

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children.

Targeted prostaglandin E2 inhibition enhances antiviral immunity through induction of type I interferon and apoptosis in macrophages.

P304

1337-1343

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1586/14787210.2014.966082

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-09-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25269880

http://www.w3.org/2001/XMLSchema#string

Targeting eicosanoid pathways in the development of novel anti-influenza drugs.

about

P2860

P2860

Targeting eicosanoid pathways in the development of novel anti-influenza drugs.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698